Getting MK-677 Dosing Right: A Step-by-Step Walkthrough

MK-677 at a glance:

• Drug class: Oral non-peptide ghrelin receptor agonist (development discontinued for FDA approval)
• Route: oral
• Typical frequency: once daily
• Half-life: approximately 4-6 hours

Dosing MK-677 correctly isn't complicated, but the details matter. The standard schedule is once daily via oral, and the key decisions happen during titration.

Standard Dosing Schedule for MK-677

Trial doses ranged from 10 to 25 mg daily.

The typical schedule for MK-677 is once daily via oral. Half-life of approximately 4-6 hours explains why this schedule works — the drug stays active long enough to support that interval.

Titration: Why Starting Low Matters

For this class of compound, gradual titration is the standard approach. The starting doses listed above are not therapeutic — they exist to let the body adapt and to reduce gastrointestinal symptoms .

A typical titration plan for MK-677 holds each dose step for at least four weeks before moving up. Faster titration is associated with more dropouts due to side effects.

Missed Doses

If a dose of MK-677 is missed: for daily schedules, the rule of thumb is to take it as soon as remembered if within a defined window, otherwise skip it and resume the regular schedule. The exact window depends on the half-life (approximately 4-6 hours) and the specific product label. Never double up to make up for a missed dose.

Dose Adjustments

Dose adjustments may be needed for the following:

• Significant weight loss or weight gain
• Side-effect intolerance at the current step
• Changes in renal or hepatic function
• Drug interactions (particularly relevant for any concurrent medications)

We cover the side-effect side of dose decisions in MK-677 side effects and the cost angle of dose escalation in MK-677 cost.

What the Trials Used

Published trial data for MK-677 comes primarily from: Nass et al. 2008, Annals of Internal Medicine — older adults trial showed muscle mass gain but no functional benefit.

That data drives the labeled dosing range, which is what physicians prescribe by.

Special Populations

The dosing guidance above applies to general adult use. Special populations — pregnancy, pediatric, severe renal impairment, hepatic dysfunction, elderly with frailty — require individualized assessment that this page can't substitute for.

For MK-677: the standard contraindications for this drug class apply.

Bottom Line

The single biggest dosing mistake we see with MK-677 is impatience — skipping titration steps to get to the goal dose faster. It almost always backfires.

Frequently Asked Questions

Related Reading

• The Honest Guide to MK-677: What Patients and Doctors Actually Say
• Is MK-677 Safe? An Honest Look at the Side-Effect Profile
• MK-677 Outcomes Decoded: Who Responds Best and Why
• Why MK-677 Costs So Much (and 5 Ways to Pay Less)
• CJC-1295 101: A Plain-English Guide for 2026
• MK-677 Cycle and Protocol: What Researchers Actually Use

Sources

• Teichman SL et al. Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295. JCEM 2006;91:799.
• Stanley TL et al. Effects of Tesamorelin on Visceral Fat in HIV-Infected Patients With Lipodystrophy. NEJM 2010;363:2425.
• Nass R et al. Effects of an Oral Ghrelin Mimetic on Body Composition in Healthy Older Adults. Annals of Internal Medicine 2008;149:601.

This page is informational only and is not medical advice. We do not provide guidance for self-administration of compounds that are not FDA-approved.